Search

Your search keyword '"Siddiqui, Bilal A."' showing total 43 results

Search Constraints

Start Over You searched for: Author "Siddiqui, Bilal A." Remove constraint Author: "Siddiqui, Bilal A." Search Limiters Full Text Remove constraint Search Limiters: Full Text
43 results on '"Siddiqui, Bilal A."'

Search Results

4. Distributed Nonlinear MPC of Multi-Agent Systems with Data Compression and Random Delays - Extended Version

5. Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments

8. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

9. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship

11. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship

13. Abstract CT211: A phase 1 dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, and anti- tumor activity of ARX517 in subjects with advanced solid tumors resistant or refractory to standard therapies (APEX-01 trial, NCT04662580)

18. 352 Target modulation within the tumor microenvironment (TME) by daratumumab (anti-CD38) but not edicotinib (CSF-1R inhibitor) in men with high-risk localized prostate cancer

19. 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome

20. 293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19

21. Etiology of acute renal failure in a tertiary center

22. Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

25. Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors

26. Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

31. Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor

32. 372. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study

38. An Empirical Analysis of New Product by Using Models of Market Research (2013)

41. JasperReports 3.6 Development Cookbook

42. Simultaneous allergic interstitial nephritis and cardiomyopathy in a patient on clozapine.

43. 2011 runner-up essay: stuffing mouths with gold: equitable solutions to the primary care physician shortage.

Catalog

Books, media, physical & digital resources